Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 372

1.

Dialysis vintage and parathyroid hormone level, not fibroblast growth factor-23, determines chronic-phase phosphate wasting after renal transplantation.

Tomida K, Hamano T, Ichimaru N, Fujii N, Matsui I, Nonomura N, Tsubakihara Y, Rakugi H, Takahara S, Isaka Y.

Bone. 2012 Oct;51(4):729-36. doi: 10.1016/j.bone.2012.06.027. Epub 2012 Jul 14.

PMID:
22796419
2.

Role of fibroblast growth factor 23 (FGF23) in the metabolism of phosphorus and calcium immediately after kidney transplantation.

Sánchez Fructuoso AI, Maestro ML, Calvo N, De La Orden V, Pérez Flores I, Vidaurreta M, Valero R, Fernández-Pérez C, Barrientos A.

Transplant Proc. 2012 Nov;44(9):2551-4. doi: 10.1016/j.transproceed.2012.09.070.

PMID:
23146451
3.

Serum level of fibroblast growth factor 23 in maintenance renal transplant patients.

Sánchez Fructuoso AI, Maestro ML, Pérez-Flores I, Valero R, Rafael S, Veganzones S, Calvo N, De la Orden V, De la Flor JC, Valga F, Vidaurreta M, Fernández-Pérez C, Barrientos A.

Nephrol Dial Transplant. 2012 Nov;27(11):4227-35. doi: 10.1093/ndt/gfs409.

PMID:
23144073
4.

Fibroblast growth factor 23, but not parathyroid hormone, is associated with urinary phosphate regulation in patients on peritoneal dialysis.

Yamada S, Tsuruya K, Tokumoto M, Yoshida H, Hasegawa S, Tanaka S, Eriguchi M, Nakano T, Masutani K, Ooboshi H, Kitazono T.

Ther Apher Dial. 2015 Feb;19(1):73-80. doi: 10.1111/1744-9987.12221. Epub 2014 Sep 4.

PMID:
25195562
5.

Fibroblast growth factor 23 and calcium phosphate homeostasis after pediatric renal transplantation.

van Husen M, Lehnhardt A, Fischer AK, Brinkert F, Loos S, Oh J, Kemper MJ.

Pediatr Transplant. 2012 Aug;16(5):443-50. doi: 10.1111/j.1399-3046.2012.01702.x. Epub 2012 May 4.

PMID:
22554017
6.

Intact fibroblast growth factor 23 levels predict incident cardiovascular event before but not after the start of dialysis.

Nakano C, Hamano T, Fujii N, Obi Y, Matsui I, Tomida K, Mikami S, Inoue K, Shimomura A, Nagasawa Y, Okada N, Tsubakihara Y, Rakugi H, Isaka Y.

Bone. 2012 Jun;50(6):1266-74. doi: 10.1016/j.bone.2012.02.634. Epub 2012 Mar 6.

PMID:
22425694
7.

Secreted Klotho and FGF23 in chronic kidney disease Stage 1 to 5: a sequence suggested from a cross-sectional study.

Pavik I, Jaeger P, Ebner L, Wagner CA, Petzold K, Spichtig D, Poster D, Wüthrich RP, Russmann S, Serra AL.

Nephrol Dial Transplant. 2013 Feb;28(2):352-9. doi: 10.1093/ndt/gfs460. Epub 2012 Nov 4.

PMID:
23129826
8.

Renal phosphate loss in long-term kidney transplantation.

Sirilak S, Chatsrisak K, Ingsathit A, Kantachuvesiri S, Sumethkul V, Stitchantrakul W, Radinahamed P, Disthabanchong S.

Clin J Am Soc Nephrol. 2012 Feb;7(2):323-31. doi: 10.2215/CJN.06380611. Epub 2011 Dec 1.

9.

The relative role of fibroblast growth factor 23 and parathyroid hormone in predicting future hypophosphatemia and hypercalcemia after living donor kidney transplantation: a 1-year prospective observational study.

Kawarazaki H, Shibagaki Y, Fukumoto S, Kido R, Nakajima I, Fuchinoue S, Fujita T, Fukagawa M, Teraoka S.

Nephrol Dial Transplant. 2011 Aug;26(8):2691-5. doi: 10.1093/ndt/gfq777. Epub 2011 Feb 8.

PMID:
21303965
10.

The impact of diabetes mellitus on vitamin D metabolism in predialysis patients.

Tanaka H, Hamano T, Fujii N, Tomida K, Matsui I, Mikami S, Nagasawa Y, Ito T, Moriyama T, Horio M, Imai E, Isaka Y, Rakugi H.

Bone. 2009 Nov;45(5):949-55. doi: 10.1016/j.bone.2009.07.016. Epub 2009 Jul 23.

PMID:
19631779
11.

Fibroblast growth factor 23 and soluble klotho in children with chronic kidney disease.

Wan M, Smith C, Shah V, Gullet A, Wells D, Rees L, Shroff R.

Nephrol Dial Transplant. 2013 Jan;28(1):153-61. doi: 10.1093/ndt/gfs411. Epub 2012 Nov 23.

PMID:
23180879
12.

Regulation of fibroblast growth factor-23 in chronic kidney disease.

Westerberg PA, Linde T, Wikström B, Ljunggren O, Stridsberg M, Larsson TE.

Nephrol Dial Transplant. 2007 Nov;22(11):3202-7. Epub 2007 Jun 13.

PMID:
17567652
13.

Earlier decrease of FGF-23 and less hypophosphatemia in preemptive kidney transplant recipients.

Barros X, Torregrosa JV, Martínez de Osaba MJ, Casals G, Paschoalin R, Durán CE, Campistol JM.

Transplantation. 2012 Oct 27;94(8):830-6. doi: 10.1097/TP.0b013e318264fc08.

PMID:
23018879
15.

Abnormalities in renal tubular phosphate handling in children with sickle cell disease.

Raj VM, Freundlich M, Hamideh D, Alvarez O, Seeherunvong W, Abitbol C, Katsoufis C, Chandar J, Ruiz P, Zilleruelo G.

Pediatr Blood Cancer. 2014 Dec;61(12):2267-70. doi: 10.1002/pbc.25188. Epub 2014 Aug 17.

PMID:
25132581
16.

Combined use of vitamin D status and FGF23 for risk stratification of renal outcome.

Nakano C, Hamano T, Fujii N, Matsui I, Tomida K, Mikami S, Inoue K, Obi Y, Okada N, Tsubakihara Y, Isaka Y, Rakugi H.

Clin J Am Soc Nephrol. 2012 May;7(5):810-9. doi: 10.2215/CJN.08680811. Epub 2012 Feb 23.

17.

The impact of vitamin D status on the relative increase in fibroblast growth factor 23 and parathyroid hormone in chronic kidney disease.

Taal MW, Thurston V, McIntyre NJ, Fluck RJ, McIntyre CW.

Kidney Int. 2014 Aug;86(2):407-13. doi: 10.1038/ki.2013.537. Epub 2014 Jan 15.

PMID:
24429404
19.

Assessment of tubular reabsorption of phosphate as a surrogate marker for phosphate regulation in chronic kidney disease.

Hong YA, Lim JH, Kim MY, Kim Y, Yang KS, Chung BH, Chung S, Choi BS, Yang CW, Kim YS, Chang YS, Park CW.

Clin Exp Nephrol. 2015 Apr;19(2):208-15. doi: 10.1007/s10157-014-0962-5. Epub 2014 Apr 1.

PMID:
24682550
20.

Soluble klotho and autosomal dominant polycystic kidney disease.

Pavik I, Jaeger P, Ebner L, Poster D, Krauer F, Kistler AD, Rentsch K, Andreisek G, Wagner CA, Devuyst O, Wüthrich RP, Schmid C, Serra AL.

Clin J Am Soc Nephrol. 2012 Feb;7(2):248-57. doi: 10.2215/CJN.09020911. Epub 2011 Dec 22.

Supplemental Content

Support Center